Acquired von Willebrand disease in myeloproliferative disorders

Leukemia & Lymphoma
P J van GenderenU Budde

Abstract

The laboratory features of acquired von Willebrand defect (AvWD) in myeloproliferative disorders (MPD) are characterized by a very high platelet count, a normal or prolonged bleeding time, a normal factor VIII and von Willebrand factor (vWF) antigen level, but a decreased vWF-ristocetine cofactor activity and collagen binding activity with a decrease or absence of large vWF-multimers simulating a type II von Willebrand factor deficiency. Although the pathogenesis of type II AvWD in MPD remains unclear, evidence is accumulating that the increased number of platelets in the circulating blood seems to be directly responsible for the observed decrease of large vWF-multimers in plasma leading to a spontaneous bleeding tendency at very high platelet counts. This observation may have clinical implications for the use of platelet anti-aggregants such as aspirin in MPD at platelet counts in excess of 1000 to 2000 x 10(9)/L.

References

Jan 1, 1991·Pediatric Radiology·P G Gallagher, W S Ball
Aug 1, 1990·Cancer·P FenauxF Bauters
Oct 1, 1987·American Journal of Hematology·H Mohri
Jan 1, 1988·Clinical and Laboratory Haematology·W TatewakiA Shibata
Jul 1, 1987·American Journal of Clinical Pathology·B K RamanS M Saeed
Jan 1, 1994·Scandinavian Journal of Rheumatology·A J GeirssonL P Asgeirsdóttir

❮ Previous
Next ❯

Citations

May 23, 1998·Blood Reviews·S Willoughby, T C Pearson
Jul 29, 1999·Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·I B Johnstone
Mar 6, 2016·Journal of Hematology & Oncology·A KaifieUNKNOWN Study Alliance Leukemia (SAL)
Jun 25, 2020·Journal of Thrombosis and Thrombolysis·Milan KošťálUNKNOWN for CZEMP–Czech Group for Ph- Myeloproliferative neoplasms

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Maria Luigia RandiAntonio Girolami
Baillière's Clinical Haematology
W J Oczkowski, A G Turpie
Annals of the New York Academy of Sciences
J J MichielsH H van Vliet
© 2021 Meta ULC. All rights reserved